Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Tetrathiomolybdate Inhibits Copper Trafficking Proteins through Metal Cluster Formation

Hamsell M. Alvarez, Yi Xue, Chandler D. Robinson, Mónica A. Canalizo-Hernández, Rebecca G. Marvin, Rebekah A. Kelly, Alfonso Mondragón, James E. Penner-Hahn and Thomas V. O'Halloran
Science
New Series, Vol. 327, No. 5963 (Jan. 15, 2010), pp. 331-334
Stable URL: http://www.jstor.org/stable/40508536
Page Count: 4
  • More info
  • Cite this Item
Tetrathiomolybdate Inhibits Copper Trafficking Proteins through Metal Cluster Formation
Preview not available

Abstract

Tetrathiomolybdate (TM) is an orally active agent for treatment of disorders of copper metabolism. Here we describe how TM inhibits proteins that regulate copper physiology. Crystallographic results reveal that the surprising stability of the drug complex with the metallochaperone Atx1 arises from formation of a sulfur-bridged copper-molybdenum cluster reminiscent of those found in molybdenum and iron sulfur proteins. Spectroscopic studies indicate that this cluster is stable in solution and corresponds to physiological clusters isolated from TM-treated Wilson's disease animal models. Finally, mechanistic studies show that the drug-metallochaperone inhibits metal transfer functions between copper-trafficking proteins. The results are consistent with a model wherein TM can directly and reversibly down-regulate copper delivery to secreted metalloenzymes and suggest that proteins involved in metal regulation might be fruitful drug targets.

Page Thumbnails

  • Thumbnail: Page 
331
    331
  • Thumbnail: Page 
332
    332
  • Thumbnail: Page 
333
    333
  • Thumbnail: Page 
334
    334